Integrating counseling about medication adherence into psychotherapy for depression for people living with HIV can improve both adherence and depression, according to a new study co-authored by a Boston University School of Public Health (BUSPH) researcher.
The study, in The Lancet HIV, recommends that mental health providers “consider adding adherence counseling into their psychiatric treatment of patients with HIV who have comorbid depression and poor HIV medication adherence.”
The authors, including Dr. Michael Stein, chair and professor of health law, policy & management at BUSPH, said cost-effectiveness analyses are needed to further examine the use of this dual intervention.
“This clearly shows the benefits of dealing with medication adherence and depression together, rather than trying to tackle them separately,” Dr. Stein said. “One session of adherence counseling and only modest attention to patients’ depression just isn’t enough to improve adherence.”
To read more about the study, go to: http://www.bu.edu/sph/2016/10/06/integrated-approach-improves-medication-adherence-and-depression-in-hiv-patients/